Management

Suresh K. Jain, Ph.D., Founder and CEO

Suresh is a successful entrepreneur with an impressive track record of building world-class organizations. As the former Director and Head of Drug Discovery at Galenea Corp. and Group Head at Millennium Pharmaceuticals Suresh has worked in the pharmaceutical industry for many years and has received several achievement awards. Suresh has a deep understanding of the global outsourcing industry and the commitment to bring affordable and flexible research outsourcing to bear in the fight to bring new drugs to market. Suresh holds a Ph.D. in Biochemistry (Human Anatomy) from the All-India Institute of Medical Sciences, New Delhi, India

Roydon Price, Ph.D., VP of US Operations.

Roydon has a strong basic science background and extensive experience in the drug discovery. Heading the inflammation team at CombinatoRx Inc. gave Roydon a unique understanding of the process of taking leads from the bench into the clinic. Roydon holds a Ph.D. from Harvard University, Biological Chemistry and Molecular Pharmacology.

Victor Shifrin, Ph.D., Director of Early Discovery Research

Victor brings to ITI over 20 years of background in academia and pharmaceutical industry. With experience at Surface Logix, Scriptgen, Eisai Research Institute, and CombinatoRx, Victors provides seasoned advice about in vitro pharmacology, early drug discovery, and high throughput screening (HTS), Victor holds a Ph.D from Harvard University, Cell and Developmental Biology Program.